These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34187491)

  • 1. Associations between exposure to perfluoroalkyl substances and body fat evaluated by DXA and MRI in 109 adolescent boys.
    Thomsen ML; Henriksen LS; Tinggaard J; Nielsen F; Jensen TK; Main KM
    Environ Health; 2021 Jun; 20(1):73. PubMed ID: 34187491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018-2020.
    Kang H; Kim SH
    Int J Hyg Environ Health; 2024 Jun; 259():114385. PubMed ID: 38676994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral difficulties in 7-year old children in relation to developmental exposure to perfluorinated alkyl substances.
    Oulhote Y; Steuerwald U; Debes F; Weihe P; Grandjean P
    Environ Int; 2016 Dec; 97():237-245. PubMed ID: 27692925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Concentrations of Per- and Polyfluoroalkyl Substances and Body Composition From Mid-Childhood to Early Adolescence.
    Janis JA; Rifas-Shiman SL; Seshasayee SM; Sagiv S; Calafat AM; Gold DR; Coull BA; Rosen CJ; Oken E; Fleisch AF
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3760-e3770. PubMed ID: 33740056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Per- and Polyfluoroalkyl Substance Plasma Concentrations and Bone Mineral Density in Midchildhood: A Cross-Sectional Study (Project Viva, United States).
    Cluett R; Seshasayee SM; Rokoff LB; Rifas-Shiman SL; Ye X; Calafat AM; Gold DR; Coull B; Gordon CM; Rosen CJ; Oken E; Sagiv SK; Fleisch AF
    Environ Health Perspect; 2019 Aug; 127(8):87006. PubMed ID: 31433236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of perfluoroalkyl substances in cord serum and association with growth indicators in newborns from Beijing.
    Shi Y; Yang L; Li J; Lai J; Wang Y; Zhao Y; Wu Y
    Chemosphere; 2017 Feb; 169():396-402. PubMed ID: 27886542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
    Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
    Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-course Exposure to Perfluoroalkyl Substances in Relation to Markers of Glucose Homeostasis in Early Adulthood.
    Valvi D; Højlund K; Coull BA; Nielsen F; Weihe P; Grandjean P
    J Clin Endocrinol Metab; 2021 Jul; 106(8):2495-2504. PubMed ID: 33890111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of perfluoroalkyl substances (PFAS) and body composition - A cross-sectional study in a middle-aged population.
    Lind PM; Lind L; Salihovic S; Ahlström H; Michaelsson K; Kullberg J; Strand R
    Environ Res; 2022 Jun; 209():112677. PubMed ID: 35074350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal trends of per- and polyfluoroalkyl substances in children's serum.
    Koponen J; Winkens K; Airaksinen R; Berger U; Vestergren R; Cousins IT; Karvonen AM; Pekkanen J; Kiviranta H
    Environ Int; 2018 Dec; 121(Pt 1):591-599. PubMed ID: 30308470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight.
    Wikström S; Lin PI; Lindh CH; Shu H; Bornehag CG
    Pediatr Res; 2020 May; 87(6):1093-1099. PubMed ID: 31835271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal concentrations of perfluoroalkyl substances and bone health in British girls at age 17.
    Jeddy Z; Tobias JH; Taylor EV; Northstone K; Flanders WD; Hartman TJ
    Arch Osteoporos; 2018 Aug; 13(1):84. PubMed ID: 30076472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: A proof-of-concept analysis.
    Alderete TL; Jin R; Walker DI; Valvi D; Chen Z; Jones DP; Peng C; Gilliland FD; Berhane K; Conti DV; Goran MI; Chatzi L
    Environ Int; 2019 May; 126():445-453. PubMed ID: 30844580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal Exposures to Perfluoroalkyl Acids and Associations with Markers of Adiposity and Plasma Lipids in Infancy: An Odense Child Cohort Study.
    Jensen RC; Andersen MS; Larsen PV; Glintborg D; Dalgård C; Timmermann CAG; Nielsen F; Sandberg MB; Andersen HR; Christesen HT; Grandjean P; Jensen TK
    Environ Health Perspect; 2020 Jul; 128(7):77001. PubMed ID: 32628516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum concentrations of perfluoroalkyl substances during pregnancy and gestational weight gain: The Avon Longitudinal Study of Parents and Children.
    Marks KJ; Jeddy Z; Flanders WD; Northstone K; Fraser A; Calafat AM; Kato K; Hartman TJ
    Reprod Toxicol; 2019 Dec; 90():8-14. PubMed ID: 31415809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
    Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
    Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Life Exposures to Perfluoroalkyl Substances in Relation to Adipokine Hormone Levels at Birth and During Childhood.
    Shelly C; Grandjean P; Oulhote Y; Plomgaard P; Frikke-Schmidt R; Nielsen F; Zmirou-Navier D; Weihe P; Valvi D
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5338-5348. PubMed ID: 31216000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal Exposure to Perfluoroalkyl Substances and Adiposity in Early and Mid-Childhood.
    Mora AM; Oken E; Rifas-Shiman SL; Webster TF; Gillman MW; Calafat AM; Ye X; Sagiv SK
    Environ Health Perspect; 2017 Mar; 125(3):467-473. PubMed ID: 27352404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study.
    Liu G; Zhang B; Hu Y; Rood J; Liang L; Qi L; Bray GA; DeJonge L; Coull B; Grandjean P; Furtado JD; Sun Q
    Environ Health; 2020 Jan; 19(1):5. PubMed ID: 31931806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.